| pubmed-article:12093988 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C0010674 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C0015733 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C0030274 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C1282910 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C0008742 | lld:lifeskim |
| pubmed-article:12093988 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:12093988 | pubmed:issue | 1 Pt 1 | lld:pubmed |
| pubmed-article:12093988 | pubmed:dateCreated | 2002-7-2 | lld:pubmed |
| pubmed-article:12093988 | pubmed:abstractText | Exocrine pancreatic function in patients with cystic fibrosis (CF) can be evaluated by direct and indirect tests. In pediatric patients, indirect tests are preferred because of their less invasive character, especially in CF patients with respiratory disease. Fecal tests are noninvasive and have been shown to have a high sensitivity and specificity. However, there is no comparative study in CF patients. Therefore, the aim of the present study was to compare the sensitivity and the specificity of the fecal elastase-1 (E1) test with the fecal chymotrypsin (ChT) test in a large cohort of CF patients and healthy subjects (HS). | lld:pubmed |
| pubmed-article:12093988 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12093988 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12093988 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12093988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12093988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12093988 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12093988 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12093988 | pubmed:issn | 1098-4275 | lld:pubmed |
| pubmed-article:12093988 | pubmed:author | pubmed-author:HerzigKarl-He... | lld:pubmed |
| pubmed-article:12093988 | pubmed:author | pubmed-author:WalkowiakJaro... | lld:pubmed |
| pubmed-article:12093988 | pubmed:author | pubmed-author:StrzykalaKrys... | lld:pubmed |
| pubmed-article:12093988 | pubmed:author | pubmed-author:PrzyslawskiJu... | lld:pubmed |
| pubmed-article:12093988 | pubmed:author | pubmed-author:KrawczynskiMa... | lld:pubmed |
| pubmed-article:12093988 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12093988 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:12093988 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12093988 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12093988 | pubmed:pagination | e7 | lld:pubmed |
| pubmed-article:12093988 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:meshHeading | pubmed-meshheading:12093988... | lld:pubmed |
| pubmed-article:12093988 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12093988 | pubmed:articleTitle | Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. | lld:pubmed |
| pubmed-article:12093988 | pubmed:affiliation | Institute of Pediatrics, Karol Marcinkowski University of Medical Sciences, Poznan, Poland. jarwalk@am.poznan.pl | lld:pubmed |
| pubmed-article:12093988 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12093988 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12093988 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
